Design Improvements With SONNET 3 (NCT06597747) | Clinical Trial Compass
CompletedNot Applicable
Design Improvements With SONNET 3
United States20 participantsStarted 2024-12-16
Plain-language summary
Measuring user-reported satisfaction with the latest behind-the-ear (BTE) audio processor model.
Who can participate
Age range7 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Implanted with a MED-EL cochlear implant in at least one ear
* ≥ 12 months since activation of the MED-EL audio processor
* Consistently using a SONNET (EAS) or SONNET 2 (EAS) Audio Processor
* Ability to complete all study procedures
* Participant and parental (if applicable) commitment to comply with all study procedures for the duration of the study
Exclusion Criteria:
* Evidence that hearing loss is retrocochlear in origin
* Unable to provide reliable feedback during cochlear implant programming
* Skin or scalp condition precluding use of the study device
* Unrealistic participant or parent (if applicable) motivation or expectations
* Participants without a stable fitting map at enrollment e.g., due to changes in hearing, global health status, etc.
What they're measuring
1
Participants Reporting Improvement With SONNET 3 Design